cetylpyridinium chloride anhydrous has been researched along with dihydrotestosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, AM; Biggs, ML; Cappola, AR; Hirsch, CH; Kizer, JR; Longstreth, WT; Marck, BT; Matsumoto, AM; Shores, MM; Smith, NL | 1 |
| Amory, JK; Cooper, LA; Lin, DW; Marck, BT; Matsumoto, AM; Page, ST; Rubinow, KB; Thirumalai, A; Wright, JL | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and dihydrotestosterone
| Article | Year |
|---|---|
Stable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone.
Topics: Adult; Dihydrotestosterone; Gonadotropin-Releasing Hormone; Health; Hormone Replacement Therapy; Humans; Male; Middle Aged; Oligopeptides; Orchiectomy; Prostate; Testosterone; Treatment Outcome | 2016 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and dihydrotestosterone
| Article | Year |
|---|---|
Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Cardiovascular Physiological Phenomena; Dihydrotestosterone; Health; Humans; Incidence; Longitudinal Studies; Male; Stroke; Testosterone | 2014 |